Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leiomyoma 12 Menorrhagia 4 Endometriosis 1

Interventions

relugolix 4 Sutures 2 vilaprisan 1 tibolone 1 cetrorelix 1 Uterine Myomectomy 1 Triptorelin Pamoate 1 Transcranial Direct Current Stimulation 1 Tablets 1 Surgical Procedures, Operative 1 Surgical Instruments 1 Rocuronium 1 Robotic Surgical Procedures 1 Radiotherapy 1 Radiation 1 Norethindrone Acetate 1 Menotropins 1 LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1 Indocyanine Green 1 Incidence 1 Immunonutrition Diet 1 Hysteroscopy 1 Hysterectomy 1 Gonadotropins 1 Gonadotropin-Releasing Hormone 1 Fluconazole 1 Estradiol 1 Endoscopes 1 Electrocoagulation 1 Danazol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Endometriosis × vilaprisan × Clear all

NCT03411980 2019-12-03

Pharmacokinetics and Safety of Vilaprisan in Renal Impairment

Bayer

Phase 1 Completed

Endometriosis, Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡